Case filing & court posture: Alachua Government Services, Inc., a GMP-certified biologics CDMO formerly known as Nanotherapeutics, filed for chapter 11 on July 6, 2025 in the District of Delaware (Case No. 25-11289). Dkt. 1 The case is assigned to Judge J. Kate Stickles.
Liquidity & financing path: The Debtor obtained a $17 million DIP facility from JMB Capital Partners at 13.5% interest, approved on an interim basis on July 11, 2025 Dkt. 43 and on a final basis on August 18, 2025. Dkt. 141
Alachua Site sale: The Court approved bidding procedures for the sale of the Debtor's real and personal property assets in Alachua, Florida on September 30, 2025. Dkt. 247 The sale to Strive Specialties, Inc. for $11.5 million was approved on October 17, 2025 Dkt. 307 and closed on October 30, 2025. Dkt. 331
Royalty assets sale: The Debtor filed a motion to sell its royalty assets on November 21, 2025 Dkt. 369 with bidding procedures approved on December 5, 2025. Dkt. 403 Emergent BioSolutions was designated as stalking horse bidder Dkt. 462 and the Court approved the royalty assets sale on February 10, 2026. Dkt. 533
Current status: The case remains open as the Debtor winds down operations. No liquidating plan has been filed; exclusivity was extended. A second omnibus motion to reject executory contracts was filed following the Alachua Site closing. Dkt. 335
